Fresenius Medical Care (FMEG.DE): CMS 2026 ESRD rate proposal- lots of moving parts but better than it seems in our view

Research evidence excerpt

Fresenius Medical Care (FMEG.DE): CMS 2026 ESRD rate proposal- lots of moving parts but better than it seems in our view

are.

Citigroup Global Markets Inc. or its affiliates received compensation for products and services other than investment banking

services from Fresenius Medical Care in the past 12 months.

Citigroup Global Markets Inc. or its affiliates currently has, or had within the past 12 months, the following as investment

banking client(s): Fresenius Medical Care.

Citigroup Global Markets Inc. or its affiliates currently has, or had within the past 12 months, the following as clients, and the

services provided were non-investment-banking, securities-related: Fresenius Medical Care.

services provided were non-investment-banking, non-securities-related: Fresenius Medical Care.

Citigroup Global Markets Inc. and/or its affiliates has a significant financial interest in relation to Fresenius Medical Care. (For

an explanation of the determination of significant financial interest, please refer to the policy for managing conflicts of interest

which can be found at www.citiVelocity.com.)

Analysts’ compensation is determined by Citi Research management and Citigroup’s senior management and is based upon

activities and services intended to benefit the investor clients of Citigroup Global Markets Inc. and its affiliates (the “Firm”).

Compensation is not linked to specific transactions or recommendations. Like all Firm employees, analysts receive

compensation that is impacted by overall Firm profitability which includes investment banking, sales and trading, and

principal trading revenues. One factor in equity research analyst compensation is arranging corporate access events between